amedica
-
Biologics
Amedica Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule
SALT LAKE CITY, August 20, 2015 – Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a…
Read More » -
Extremities
Amedica to Present Research Supporting Femoral Head Development at the International Society for Technology in Arthroplasty
SALT LAKE CITY, August 4, 2015 – Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform…
Read More » -
Financial
Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
SALT LAKE CITY, July 27, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics…
Read More » -
Financial
Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
SALT LAKE CITY, July 27, 2015 – Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform…
Read More » -
Biologics
Amedica Corporation Signs Additional OEM Letter of Intent Supply Agreement
SALT LAKE CITY, July 23, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics…
Read More » -
Financial
Amedica Annual Shareholder Meeting Results
As filed with the SEC on 5/21 Proposal No. 1: A proposal to approve an amendment to the Company’s 2012 Equity…
Read More » -
Financial
Amedica Corporation Reports Fourth Quarter and Full Year 2014 Financial Results
SALT LAKE CITY, March 5, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride…
Read More » -
Spine
Amedica Announces Participation in 14th Annual Needham Healthcare Conference
SALT LAKE CITY, March 31, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride…
Read More » -
Spine
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers With Porous Silicon Nitride Center
SALT LAKE CITY, Feb. 12, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride…
Read More » -
Financial
Amedica Announces Steps to Simplify Organization and Align Financial Objectives
SALT LAKE CITY, January 12, 2015 – Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform,…
Read More » -
Recon
Amedica’s Spinal Interbody Spacers with Porous Silicon Nitride Center Provide Equivalent Fusion to PEEK Spacers with Bone Autograft
SALT LAKE CITY, January 5, 2015 – Amedica Corporation (Nasdaq:AMDA), a biomaterial company that develops and commercializes silicon nitride ceramics, today released the…
Read More » -
Financial
Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
SALT LAKE CITY, December 18, 2014 – Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform…
Read More » -
Spine
Amedica Corporation Announces Private Label Agreement With Spinal Kinetics
SALT LAKE CITY, Oct. 14, 2014 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride…
Read More » -
Recon
Amedica Corporation Appoints New President and Chief Executive Officer
SALT LAKE CITY, Sept. 30, 2014 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a commercial biomaterial company focused on using its…
Read More »